Insider buying
4 insiders4 directors
Open-market purchases, traded Nov 13, 2026. Each amount is that person's own.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 23 min ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Open-market purchases, traded Nov 13, 2026. Each amount is that person's own.
Lately at Itg: the stock fell 23% in one session on Nov 5 with press coverage; it reported its results on Nov 12; the stock is up 7% in 30 days.
Insider buying
First insider buy since Nov 2022Traded Nov 17 · filed the same day
Since the trade −3.0% · S&P 500 −5.8% · to Nov 20
Bought 57% below the 52-week high, RSI 27, 44% under its 200-day average, 39 points behind the S&P 500 over 3 months
The CEO of Neuropace paid $99K out of pocket for Neuropace shares. 2 other people at Neuropace bought some too, in the same month. Shares held went up 9% with this purchase.
Lately at Neuropace: the stock fell 37% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is down 39% in 30 days.
Insider buying
3 insiders in a week, 6th time since 2006Traded Nov 16 · filed 1 day later
Since the trade −2.9% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 34, 38% under its 200-day average, 21 points behind the S&P 500 over 3 months
A Lineage Cell Therapeutics director paid $20K out of pocket for Lineage Cell Therapeutics shares. 4 other people at Lineage Cell Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Lately at Lineage Cell Therapeutics: it completed buying or selling a business or assets on Nov 12; the stock is down 19% in 30 days; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their largest buy since 2025Traded Nov 17 · filed the same day
Since the trade −2.3% · S&P 500 −5.8% · to Nov 20
Bought 38% below the 52-week high, RSI 55, 10% under its 200-day average
A Data I/O director paid $51K out of pocket for Data I/O shares. 1 other person at Data I/O bought some too, in the same month. It was the first purchase in 18 months.
Lately at Data I/O: it reported its results on Nov 12; the stock is 39% below its 12-month high; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Sep 2025Traded Nov 13 · filed 4 days later
Since the trade −16.8% · S&P 500 −8.6% · to Nov 20
Bought 25% below the 52-week high, RSI 66, 26% above its 200-day average
An Angel Studios director paid $682K out of pocket for Angel Studios shares. It was the first purchase in over a year. Shares held went up 11% with this purchase.
Lately at Angel Studios: the stock rose 15% in one session on Nov 11 around a company release; it reported its results on Nov 10; the stock is up 9% in 30 days.
Insider buying
3 insiders in a week, a first since 2006Traded Nov 13 · filed 4 days later
Since the trade −5.3% · S&P 500 −8.6% · to Nov 20
Bought 46% below the 52-week high, RSI 60, 18% under its 200-day average, 41 points behind the S&P 500 over 3 months
A Cvd Equipment director paid $301K out of pocket for Cvd Equipment shares. 2 other people at Cvd Equipment bought some too, in the same month. Shares held went up 6% with this purchase.
Lately at Cvd Equipment: the stock rose 14% in one session on Nov 13 with press coverage; it reported its results on Nov 5; the stock is up 13% in 30 days.
Insider buying
Traded Nov 13 · filed 4 days later
A Paramount Skydance director paid $501K out of pocket for Paramount Skydance shares. Shares held went up 75% with this purchase.
Lately at Paramount Skydance Corporation: it reported its results on Nov 9; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
6 insiders in a week, 5th time since 2015Traded Nov 16 · filed 1 day later
Since the trade −18.2% · S&P 500 −6.8% · to Nov 20
Bought 80% below the 52-week high, RSI 46, 61% under its 200-day average, 52 points behind the S&P 500 over 3 months
A major shareholder of Babcock & Wilcox Enterprises paid $212K out of pocket for Babcock & Wilcox Enterprises shares. 5 other people at Babcock & Wilcox Enterprises bought some too, in the same month.
Lately at Babcock & Wilcox Enterprises: it reported its results on Nov 9; the stock is down 24% in 30 days; insiders made 8 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
3 insiders in a week, a first since 2020Traded Nov 16 · filed 1 day later
Since the trade −5.9% · S&P 500 −6.8% · to Nov 20
Bought 50% below the 52-week high, RSI 40, 33% under its 200-day average, 33 points behind the S&P 500 over 3 months
The CFO of MP Materials paid $129K out of pocket for MP Materials shares. 2 other people at MP Materials bought some too, in the same month.
Lately at MP Materials: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 8 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 17 · filed the same day
Since the trade −3.3% · S&P 500 −5.8% · to Nov 20
A Suncrete director paid $238K out of pocket for Suncrete shares. 6 other people at Suncrete bought some too, in the same month.
Lately at Suncrete: the stock rose 24% in one session on Nov 18 with press coverage; it reported its results on Nov 13; the stock is down 38% in 30 days.
Insider buying
4 insiders in a week, 2nd time since 2021Traded Nov 13 · filed 4 days later
Since the trade −10.2% · S&P 500 −8.6% · to Nov 20
Bought within 1% of the 52-week low, RSI 30, 29% under its 200-day average, 32 points behind the S&P 500 over 3 months
An Angel Oak Mortgage REIT director paid $30K out of pocket for Angel Oak Mortgage REIT shares. 4 other people at Angel Oak Mortgage REIT bought some too, in the same month. It was the first purchase in over a year.
Lately at Angel Oak Mortgage REIT: the stock fell 12% in one session on Nov 3 around a company release; it reported its results on Nov 3; the stock is down 25% in 30 days.
Traded Nov 16, 2026 · largest single transaction ~$939K
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Nov 16, 2026~$939K · 6,309 sh @ $148.80
DetailsOfficial recordNov 16, 2026~$927K · 6,191 sh @ $149.72
DetailsOfficial recordInsider buying
Traded Nov 13 · filed 4 days later
Since the trade −7.0% · S&P 500 −8.6% · to Nov 20
Bought within 4% of the 52-week low, RSI 30, 20% under its 200-day average, 16 points behind the S&P 500 over 3 months
Pampa Energy's Vicepresident paid $169K out of pocket for Pampa Energy shares. 3 other people at Pampa Energy bought some too, in the same month.
Lately at Pampa Energy: the stock is down 22% in 30 days; insiders made 24 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed 1 day later
Since the trade −3.4% · S&P 500 −6.8% · to Nov 20
Bought within 1% of the 52-week low, RSI 36, 32% under its 200-day average, 18 points behind the S&P 500 over 3 months
The CEO of Sensus Healthcare paid $72K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month.
Lately at Sensus Healthcare: the stock fell 28% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is down 21% in 30 days.
Insider buying
First buy since 2021Traded Nov 16 · filed 1 day later
Since the trade −1.5% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 33, 33% under its 200-day average, 24 points behind the S&P 500 over 3 months
The CFO of Alphatec paid $99K out of pocket for Alphatec shares. 2 other people at Alphatec bought some too, in the same month.
Lately at Alphatec Holdings: the stock fell 38% in one session on Oct 30 around a company release; it reported its results on Oct 29; the stock is down 38% in 30 days.
Insider buying
First insider buy since Sep 2025Traded Nov 13 · filed 4 days later
Since the trade +9.7% · S&P 500 −8.6% · to Nov 20
Bought at the 52-week low, RSI 25, 70% under its 200-day average, 64 points behind the S&P 500 over 3 months
An Opendoor Technologies director paid $125K out of pocket for Opendoor Technologies shares. It was the first purchase in over a year. Shares held went up 29% with this purchase.
Lately at Opendoor Technologies: it reported its results on Nov 5; the stock is down 33% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.